Public health
The year 2023 has witnessed significant strides in the fight against malaria and Alzheimer's disease, marking a continued commitment to health and scientific progress despite the presumed end of the COVID-19 pandemic, as reported by the World Health Organization.
New vaccines are being rolled out globally to combat seemingly incurable diseases such as malaria and Alzheimer's. Additionally, groundbreaking technologies aim to empower paralyzed individuals to regain the ability to walk.
In a crucial development, twelve countries across various regions of Africa are set to receive a total of 18 million doses of the world's very first antimalarial vaccine over the next two years. This deployment marks a pivotal step in addressing one of the leading causes of mortality on the continent.
Countries participating in the Antimalarial Vaccination Implementation Program, including Ghana, Kenya, and Malawi, will benefit from these doses to continue vaccination efforts in pilot regions. The initiative represents a collaborative effort to bring about positive health outcomes and combat the pervasive impact of malaria in affected regions.
01:05
Controversial US-backed hepatitis B vaccine trial to move forward in Guinea-Bissau
01:06
Kenya says no new Ebola cases since first-ever death
02:00
Kenyan health ministry urges churches to raise awareness about Ebola
00:57
Zambia signs health deal with US after removal of data-sharing clauses
02:10
'I got so scared': Nairobi residents worried after Kenya's first Ebola death
01:37
MSF warns Ebola spread in DR Congo's North Kivu province is 'out of control'